Norbert Krug is professor of Immunology, Allergology and Clinical Airway Research and has been Medical Director of the Fraunhofer Institute for Toxicology and Experimental Medicine ITEM since 2008. In 2014, he became coordinator of the Clinical Research Center Hannover (CRC Hannover) in addition. At the Hannover Medical School, he trained in internal medicine and also in respiratory medicine, allergology and intensive-care medicine. From 1991 to 1993, he was a research fellow at the University of Bochum, Germany, and the University of Southampton, UK.
In 2000, he was awarded a full academic professorship in immunology, allergology and clinical airway research at the Hannover Medical School and became Division Director of Immunology, Allergology and Airway Research at Fraunhofer ITEM, where he played a leading role in setting up the clinical airway research department in the following years.
Professor Krug is a member of several international professional societies such as the German Respiratory Society, the European Respiratory Society, and the American Thoracic Society. His major research interests include translational medicine and clinical trials in allergy, asthma, and COPD, pathogenesis of allergic airway diseases (asthma, rhinitis and COPD), and air pollution and airway diseases. Professor Krug is a reviewer for numerous international journals in respiratory medicine and allergology and for a variety of research organizations. He is a member of the scientific advisory board of the German Society for Allergy and Clinical Immunology, a member of the German Center for Lung Research, and Deputy Spokesman of the Fraunhofer Group for Life Sciences. Prof. Krug took over the job of the institute’s executive director on January 1, 2017.